Balance Sheet - 4D Molecular Therapeutics, Inc. (FDMT)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 402.66 | 424.88 | 288.23 | 213.55 | 247.78 | 276.73 | 49.65 | 91.76 | 23.85 |
| Accounts receivable, net | 0.70 | 0.05 | 1.49 | 0.98 | 1.12 | 0.32 | |||
| Inventories | -5.79 | -8.50 | 0.00 | ||||||
| Other current assets | 10.48 | 10.06 | 8.36 | 6.26 | 8.46 | 4.44 | 1.88 | 0.78 | 0.33 |
| Total current assets | 413.13 | 434.93 | 296.59 | 220.51 | 256.28 | 282.66 | 52.51 | 94.07 | 24.50 |
| Total non-current assets | 153.58 | 125.45 | 43.30 | 41.34 | 97.21 | 5.68 | 5.73 | 2.90 | 2.82 |
| Total assets | 566.71 | 560.38 | 339.89 | 261.85 | 353.49 | 288.33 | 58.23 | 96.97 | 27.32 |
| Total current liabilities | 43.99 | 29.15 | 18.95 | 15.73 | 16.34 | 16.74 | 12.96 | 8.05 | 5.91 |
| Total non-current liabilities | 17.06 | 20.63 | 13.11 | 14.78 | 18.04 | 15.20 | 118.25 | 116.50 | 41.00 |
| Total liabilities | 61.05 | 49.78 | 32.06 | 30.51 | 34.38 | 31.94 | 131.20 | 124.56 | 46.91 |
| Total stockholders' equity | 505.66 | 510.61 | 307.83 | 231.34 | 319.11 | 256.39 | -72.97 | -27.59 | -19.59 |
| Common shares outstanding | 58 | 54 | 39 | 32 | 28 | 27 | 26 | 13 | 15 |
Show Quarterly Balance Sheet
Balance Sheet - 4D Molecular Therapeutics, Inc. (FDMT)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 390.89 | 402.66 | 305.06 | 293.23 | 321.44 | 424.88 | 501.89 | 541.95 | 525.91 | 288.23 | 319.66 | 310.34 | 200.45 | 213.55 | 227.72 | 241.09 | 236.15 | 247.78 | 161.68 | 243.74 | 259.87 | 276.73 | 88.76 | 0.00 | 49.65 | 49.65 | 72.87 | 72.87 | 72.87 | 91.76 | 91.76 | 0.00 | 23.85 |
| Accounts receivable, net | 0.70 | 0.00 | 0.00 | 0.00 | 0.05 | 0.79 | 1.22 | 0.97 | 1.49 | 0.90 | 0.98 | 1.16 | 1.16 | 1.12 | 1.12 | ||||||||||||||||||
| Inventories | -0.70 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||||
| Other current assets | 14.47 | 10.48 | 7.31 | 10.06 | 11.13 | 10.06 | 8.87 | 10.69 | 9.68 | 8.36 | 8.58 | 7.43 | 6.59 | 6.26 | 4.76 | 5.44 | 6.89 | 8.46 | 3.27 | 3.79 | 3.67 | 4.44 | 2.89 | 1.88 | 1.42 | 1.42 | 0.78 | 1.18 | |||||
| Total current assets | 405.36 | 413.13 | 312.38 | 303.29 | 332.57 | 434.93 | 510.76 | 552.63 | 535.59 | 296.59 | 328.24 | 317.78 | 207.04 | 220.51 | 232.48 | 246.52 | 243.05 | 256.28 | 165.73 | 248.75 | 264.50 | 282.66 | 92.54 | 49.65 | 52.51 | 72.87 | 75.45 | 75.45 | 94.07 | 94.07 | 23.85 | ||
| Total non-current assets | 107.54 | 153.58 | 111.61 | 170.35 | 183.16 | 125.45 | 93.27 | 67.48 | 94.30 | 43.30 | 33.37 | 34.73 | 36.98 | 41.34 | 47.69 | 56.41 | 81.88 | 97.21 | 74.89 | 6.18 | 5.61 | 5.68 | 5.66 | -49.65 | 5.73 | -72.87 | 5.06 | 5.06 | 2.90 | 2.90 | -23.85 | ||
| Total assets | 512.91 | 566.71 | 423.98 | 473.64 | 515.73 | 560.38 | 604.03 | 620.12 | 629.88 | 339.89 | 361.61 | 352.50 | 244.02 | 261.85 | 280.16 | 302.94 | 324.93 | 353.49 | 240.62 | 254.93 | 270.11 | 288.33 | 98.19 | 58.23 | 80.50 | 80.50 | 96.97 | 96.97 | |||||
| Total current liabilities | 43.40 | 43.99 | 37.11 | 34.68 | 26.90 | 29.15 | 29.47 | 19.40 | 16.40 | 18.95 | 18.16 | 13.75 | 11.28 | 15.73 | 13.56 | 14.33 | 12.09 | 16.34 | 11.37 | 9.87 | 13.92 | 16.74 | 14.28 | 12.96 | 8.60 | 8.60 | 8.05 | 8.05 | |||||
| Total non-current liabilities | 17.67 | 17.06 | 17.89 | 18.07 | 19.11 | 20.63 | 21.62 | 12.37 | 12.92 | 13.11 | 13.52 | 13.61 | 14.14 | 14.78 | 15.16 | 16.09 | 16.78 | 18.04 | 5.11 | 4.42 | 13.77 | 15.20 | 13.76 | 118.25 | 114.20 | 116.50 | |||||||
| Total liabilities | 61.07 | 61.05 | 55.00 | 52.75 | 46.01 | 49.78 | 51.08 | 31.78 | 29.32 | 32.06 | 31.68 | 27.36 | 25.42 | 30.51 | 28.72 | 30.42 | 28.87 | 34.38 | 16.48 | 14.29 | 27.68 | 31.94 | 28.04 | 131.20 | 122.80 | 8.60 | 124.56 | 8.05 | |||||
| Total stockholders' equity | 451.84 | 505.66 | 368.98 | 420.89 | 469.72 | 510.61 | 552.95 | 588.34 | 600.56 | 307.83 | 329.93 | 325.14 | 218.61 | 231.34 | 251.44 | 272.52 | 296.06 | 319.11 | 224.13 | 240.65 | 242.43 | 256.39 | 70.16 | 30.01 | -72.97 | 60.68 | -42.30 | 60.68 | -27.59 | 75.39 | -1.08 | ||
| Common shares outstanding | 68 | 58 | 56 | 56 | 56 | 54 | 56 | 55 | 49 | 39 | 42 | 38 | 33 | 32 | 32 | 32 | 32 | 27 | 27 | 27 | 27 | 27 | 22 | 15 | 15 | 15 | 15 | 5 | 5 | 5 | 5 | 5 | 5 |